Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

What is the Skeletal System?

What is the Skeletal System?

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Palatal myoclonus with tinnitus treated as a psychogenic disorder for 35-years.

L'Encephale·2022

Same author

SARS-CoV-2 mRNA booster vaccine-associated lichenoid drug eruption.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Same author

An ancient, Antarctic-specific species complex: large divergences between multiple Antarctic lineages of the tardigrade genus Mesobiotus.

Molecular phylogenetics and evolution·2022

Same author

A recurring blistering eruption on the palms.

Clinical and experimental dermatology·2021

Same author

Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Trabecular Bone Microarchitecture Evaluation in an Osteoporosis Mouse Model

Trabecular Bone Microarchitecture Evaluation in an Osteoporosis Mouse Model

Published on: September 8, 2023

Male osteoporosis.

M Rocchietti March¹, D Pisani, G Aliberti

¹Department of Internal Medicine, Sant'Andrea Hospital, Rome, Italy. massimiliano.rocchietti@uniroma1.it

Minerva Endocrinologica

|January 5, 2010

Summary

This summary is machine-generated.

Osteoporosis, a bone disease, affects men significantly, leading to fractures. Early diagnosis and prevention are crucial for managing this underrecognized public health issue in aging populations.

Related Experiment Videos

Last Updated: Jun 17, 2026

Trabecular Bone Microarchitecture Evaluation in an Osteoporosis Mouse Model

Trabecular Bone Microarchitecture Evaluation in an Osteoporosis Mouse Model

Published on: September 8, 2023

Area of Science:

Bone Health and Osteoporosis Research
Geriatric Medicine
Public Health

Background:

Osteoporosis is a global health concern defined by low bone mass and deterioration, increasing fracture risk.
While often studied in women, osteoporosis significantly impacts men, with projections indicating similar hip fracture rates by 2025.
A substantial percentage of men experience osteoporotic fractures, yet the condition remains underdiagnosed.

Purpose of the Study:

To highlight the growing clinical importance of osteoporosis in men.
To underscore the need for further research into male osteoporosis pathogenesis and treatment.
To emphasize the current importance of prevention and early diagnosis for managing male osteoporosis.

Main Methods:

Review of epidemiological and observational studies on male osteoporosis.
Analysis of diagnostic criteria for osteoporosis, including bone mineral density (T-score ≤ -2.5).
Examination of trends in osteoporosis prevalence and fracture risk in aging male populations.

Main Results:

Male osteoporosis is an increasingly recognized clinical issue.
Projected hip fracture numbers in men are comparable to women by 2025.
A significant lifetime risk of osteoporotic fractures exists for men (25-33%).

Conclusions:

Male osteoporosis is underdiagnosed and requires more research for effective therapies.
Prevention and early detection are currently the most effective management strategies.
Addressing male osteoporosis is essential for public health, particularly in aging societies.